Benign Essential Blepharospasm Overview
Learn About Benign Essential Blepharospasm
- Benign essential blepharospasm
- BEB
- Blepharospasm
- OBSOLETE: Benign essential blepharospasm
- Primary blepharospasm
Emory Brain Health Center
Hyder Jinnah is a Neurologist in Atlanta, Georgia. Dr. Jinnah has been practicing medicine for over 33 years and is rated as an Elite provider by MediFind in the treatment of Benign Essential Blepharospasm. His top areas of expertise are Benign Essential Blepharospasm, Drug Induced Dyskinesia, Focal Dystonia, Torticollis, and Deep Brain Stimulation.
Cleveland Clinic Main Campus
Hubert Fernandez is a Neurologist in Cleveland, Ohio. Dr. Fernandez is rated as an Elite provider by MediFind in the treatment of Benign Essential Blepharospasm. His top areas of expertise are Movement Disorders, Parkinson's Disease, Drug Induced Dyskinesia, Deep Brain Stimulation, and Gastric Bypass. Dr. Fernandez is currently accepting new patients.
Atrium Health Neurology Specialty Care, A Facility Of Carolinas Medical Center
Danielle Doggett is a Neurologist in Charlotte, North Carolina. Dr. Doggett is rated as an Advanced provider by MediFind in the treatment of Benign Essential Blepharospasm. Her top areas of expertise are Parkinson's Disease, Movement Disorders, Essential Tremor, Drug Induced Dyskinesia, and Deep Brain Stimulation. Dr. Doggett is currently accepting new patients.
Summary: To date, there is only limited knowledge about the distinct neural abnormalities that lead to the development of different forms of focal dystonia. The goal of this study is to dissect the pathophysiological mechanisms underlying this clinical phenomenon using multi-level brain network analysis in patients with focal dystonia.
Summary: The goal of this clinical trial is to test the effects of DaxibotulinumtoxinA-Lanm (Daxxify) in patients with benign essential blepharospasms (BEB) and hemifacial spasms (HFS). The main questions to answer: 1. Is there clinically significant difference (measured by Jankovic Rating Scale (JRS) score from base to peak efficacy) for patients with BEB and HFS treated with Daxxify? 2. What percentage o...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center


